A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
Status:
Completed
Trial end date:
2018-04-03
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and effectiveness of 2
concentrations of A-101 compared to Vehicle for the treatment of 4 seborrheic keratosis (SK)
Target Lesions on the trunk, extremities and face.